Use of insulin glargine during pregnancyPDYHONEN-ALHO, Maritta; RONNEMAA, Tapani; SALTEVO, Juha et al.Acta obstetricia et gynecologica Scandinavica. 2007, Vol 86, Num 10, pp 1171-1174, issn 0001-6349, 4 p.Article

Insulin glargine: a new basal insulin analogueYOUNIS, N; SORAN, H; BOWEN-JONES, D et al.QJM (Oxford. 1994. Print). 2002, Vol 95, Num 11, pp 757-761, issn 1460-2725, 5 p.Article

Dosing of insulin glargine in the treatment of type 2 diabetesBARNETT, Anthony.Clinical therapeutics. 2007, Vol 29, Num 6, pp 987-999, issn 0149-2918, 13 p.Article

Pas de lien formel entre insulîne glargine et cancerBABAI, Samy; BROCVIELLE, Hélène; LE LOUET, Hervé et al.Médecine (Montrouge). 2009, Vol 5, Num 9, issn 1777-2044, p. 399Article

Prescription of insulin glargine in primary care practices in GermanyRATHMANN, W; HAASTERT, B; RIEBEL, P et al.Experimental and clinical endocrinology & diabetes. 2007, Vol 115, Num 4, pp 252-256, issn 0947-7349, 5 p.Article

Fasting and insulin glargine in individuals with type 1 diabetesMUCHA, Gregory T; MERKEL, Stacia; THOMAS, William et al.Diabetes care. 2004, Vol 27, Num 5, pp 1209-1210, issn 0149-5992, 2 p.Article

Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glarginePING WU; CHENG JI; MINGLI WANG et al.Annales d'endocrinologie. 2013, Vol 74, Num 1, pp 56-58, issn 0003-4266, 3 p.Article

Early retinopathy progression in four randomized trials comparing insulin glargine and Nph insulinDAVIS, M. D; BECK, R. W; HOME, P. D et al.Experimental and clinical endocrinology & diabetes. 2007, Vol 115, Num 4, pp 240-243, issn 0947-7349, 4 p.Article

Triple therapy in type 2 diabetes : Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patientsROSENSTOCK, Julio; SUGIMOTO, Danny; STRANGE, Poul et al.Diabetes care. 2006, Vol 29, Num 3, pp 554-559, issn 0149-5992, 6 p.Article

Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylureaTRIPLITT, Curtis; GLASS, Leonard; MIYAZAKI, Yoshiniro et al.Diabetes care. 2006, Vol 29, Num 11, pp 2371-2377, issn 0149-5992, 7 p.Article

Optimization of basal insulin delivery in Type 1 diabetes : a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargineFAHLEN, M; ELIASSON, B; ODEN, A et al.Diabetic medicine. 2005, Vol 22, Num 4, pp 382-386, issn 0742-3071, 5 p.Article

Reduced hypoglycemia risk with insulin glargine : A meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetesROSENSTOCK, Julio; DAILEY, George; MASSI-BENEDETTI, Massimo et al.Diabetes care. 2005, Vol 28, Num 4, pp 950-955, issn 0149-5992, 6 p.Article

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes : A randomized trialHEINE, Robert J; VAN GAAL, Luc F; JOHNS, Don et al.Annals of internal medicine. 2005, Vol 143, Num 8, pp 559-569, issn 0003-4819, 11 p.Article

Glargine and regular human insulin similarly acutely enhance endothelium-dependent vasodilatation in normal subjectsWESTERBACKA, Jukka; BERGHOLM, Robert; TIIKKAINEN, Mirja et al.Arteriosclerosis, thrombosis, and vascular biology. 2004, Vol 24, Num 2, pp 320-324, issn 1079-5642, 5 p.Article

Le médicament du mois : Insuline glargine (Lantus®) = Insulin glargine (Lantus®)SCHEEN, A. J.RMLG. Revue médicale de Liège. 2004, Vol 59, Num 2, pp 110-114, issn 0370-629X, 5 p.Article

Les 3 molécules de l'année = The 3 drugs of the yearSTERNON, J.Revue médicale de Bruxelles. 2003, Vol 24, Num 4, pp A376-A377, issn 0035-3639Conference Paper

A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in Patients with type 1 diabetesRASKIN, Philip; KLAFF, Leslie; BERGENSTAL, Richard et al.Diabetes care. 2000, Vol 23, Num 11, pp 1666-1671, issn 0149-5992Article

Cancer Incidence Among Those Initiating Insulin Therapy With Glargine Versus Human NPH InsulinSTÜRMER, Til; ALISON MARQUIS, M; BUSE, John B et al.Diabetes care. 2013, Vol 36, Num 11, pp 3517-3525, issn 0149-5992, 9 p.Article

Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 DiabetesLUCIDI, Paola; PORCELLATI, Francesca; ROSSETTI, Paolo et al.Diabetes care. 2012, Vol 35, Num 12, pp 2647-2649, issn 0149-5992, 3 p.Article

Risque de cancers chez des patients diabétiques traités par insuline glargine ? = Risk of malignancies in patients with diabetes treated with insulin glargineLa Revue Prescrire. 2010, Vol 30, Num 318, pp 268-270, issn 0247-7750, 3 p.Article

Mixing rapid-acting insulin analogues with insulin glargine in children with type 1 diabetes mellitusFIALLO-SCHARER, Rosanna; HORNER, Brian; MCFANN, Kim et al.The Journal of pediatrics. 2006, Vol 148, Num 4, pp 481-484, issn 0022-3476, 4 p.Article

Les nouvelles insulines : intérêts et inconvénients = New insulins : interests and convenientsSOLA, A; LARGER, E; M'BEMBA, J et al.Réanimation (Paris. 2001). 2006, Vol 15, Num 6, pp 454-460, issn 1624-0693, 7 p.Article

Early hypoglycaemia after accidental intramuscular injection of insulin glargineKARGES, B; BOEHM, B. O; KARGES, W et al.Diabetic medicine. 2005, Vol 22, Num 10, pp 1444-1445, issn 0742-3071, 2 p.Article

Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine hagedorn insulinCHASE, H. Peter; DIXON, Brenner; PEARSON, Jerusha et al.The Journal of pediatrics. 2003, Vol 143, Num 6, pp 737-740, issn 0022-3476, 4 p.Article

Intravenous glargine and regular insulin have similar effects on endogenous glucose output and peripheral activation/deactivation kinetic profilesMUDALIAR, Sunder; MOHIDEEN, Pharis; DEUTSCH, Reena et al.Diabetes care. 2002, Vol 25, Num 9, pp 1597-1602, issn 0149-5992Article